Robert Walker discusses the updated COVID-19 vaccines targeting the new JN.1 lineage of the virus and the challenges of addressing vaccine hesitancy to protect individuals and communities.Robert Walker, MD, senior vice president, chief medical officer, and interim head of research and development at Novavax, explains that the COVID-19 pandemic has entered a new phase, with […]
